CLINICAL RESPONSE AND DISCONTINUATION OVER TIME IN PHASE 3 TRIALS OF ELUXADOLINE FOR IRRITABLE BOWEL SYNDROME WITH DIARRHOEA

Anne Marciniak  1     Robyn T. Carson  2     Jessica L. Abel  2     David A. Andrae  3     Kelly Fust  4     Debbie Becker  5    
1 Allergan plc,Marlow,United Kingdom
2 Allergan plc,Jersey City,United States of America
3 Allergan plc,Austin,United States of America
4 Optum,Plymouth,United States of America
5 Optum,Burlington,Canada

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing